Market Tracker

01/16 8:28am ET

Endocyte Inc (NASDAQ:ECYT)

4.06
Delayed Data
As of Jan 12
 +0.02 / +0.50%
Today’s Change
1.17
Today|||52-Week Range
6.55
-5.14%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close4.04
Today’s open4.07
Day’s range4.02 - 4.12
Volume397,519
Average volume (3 months)2,399,977
Market cap$172.9M
Data as of 4:00pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)-6.12%
Earnings growth (this year)-19.23%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,537.67
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
ATXIAvenue Therapeutics ...+0.16+4.19%
CASICASI Pharmaceuticals...-0.03-0.79%
PLXPPLX Pharma Inc-0.25-3.79%
AGLEAeglea Bio Therapeut...+0.26+4.33%
Data as of 4:00pm ET, 01/12/2018

Financials

Next reporting dateFebruary 26, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$70.0K
Annual profit (last year)-$43.9M
Net profit margin-62,696.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts